États-Unis · Plateformes & données · MarketBeat

Twist Bioscience Q4 Earnings Call Highlights

Publié par MarketBeat · États-Unis il y a 22 min

Image from MarketBeat Media, LLC. · MarketBeat

Résumé détaillé

Twist Bioscience (NASDAQ:TWST) reported 28% revenue growth and positive adjusted EBITDA for its fiscal fourth quarter, as demand for DNA, proteins and data used in AI drug discovery helped drive a 22% increase in full-year sales. The company forecast fiscal 2027 revenue of $550 million to $560 mill

Lire l'article complet sur MarketBeat Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.marketbeat.com)

Twist Bioscience Q4 Earnings Call Highlights

Résumé détaillé

À lire aussi

Peraso appoints Kevin Liu as interim CFO

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

SpaceX, Tesla merger talks progress, Bloomberg News reports

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

This Analyst Sees Huang's Resignation As Nvidia CEO As A 'One-Time Clearing Event' For Stock Market

Twist Bioscience Q4 Earnings Call Highlights

Résumé détaillé

Partager

À lire aussi

Peraso appoints Kevin Liu as interim CFO

The S&P 500 is shrugging off Nvidia’s selloff this week. Here’s what’s keeping the rest of the market afloat.

SpaceX, Tesla merger talks progress, Bloomberg News reports

In a policy switch, the Fed says its October 2027 meeting will not see a vote on interest rates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

This Analyst Sees Huang's Resignation As Nvidia CEO As A 'One-Time Clearing Event' For Stock Market